Compare GNLX & CXE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GNLX | CXE |
|---|---|---|
| Founded | 2001 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 113.6M | 117.6M |
| IPO Year | 2022 | N/A |
| Metric | GNLX | CXE |
|---|---|---|
| Price | $2.96 | $3.64 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $17.25 | N/A |
| AVG Volume (30 Days) | ★ 161.3K | 92.4K |
| Earning Date | 05-12-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 4.36% |
| EPS Growth | ★ 9.47 | N/A |
| EPS | N/A | ★ 0.07 |
| Revenue | ★ $8,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $52.21 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.29 | $3.40 |
| 52 Week High | $8.54 | $3.88 |
| Indicator | GNLX | CXE |
|---|---|---|
| Relative Strength Index (RSI) | 54.44 | 38.95 |
| Support Level | $2.33 | $3.63 |
| Resistance Level | $3.25 | $3.76 |
| Average True Range (ATR) | 0.17 | 0.03 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 46.08 | 17.65 |
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.
Mfs High Income Municipal Trust is a United States-based diversified closed-end management investment company. Its investment objective is to seek high current income exempt from federal income tax. The fund invests a majority of its net assets, including assets attributable to preferred shares and borrowings for investment purposes, in tax-exempt bonds and tax-exempt notes. The company's investment portfolio has shares from the industry Healthcare, Airports, and Secondary Schools.